Mycobacterium tuberculosis increases IP-10 and MIG protein despite inhibition of IP-10 and MIG transcription

Tuberculosis

Volumn 91, Issue 1, 2011, Pages 26-35

  Bai, Xiyuan ^a   Chmura, Kathryn ^a   Ovrutsky, Alida R ^a   Bowler, Russell P ^a,b   Scheinman, Robert I ^a   Oberley Deegan, Rebecca E ^b   Liu, Haiying ^d   Shang, Shaobin ^e   Ordway, Diane ^e   Chan, Edward D ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

^d PEKING UNION MEDICAL COLLEGE   (China)

^e Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

IFN signaling; Macrophages; Nuclear factor kappa B; p38 mitogen activated protein kinase; Tuberculosis

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ARTICLE; CYTOKINE PRODUCTION; DNA FLANKING REGION; GENETIC TRANSCRIPTION; HOST RESISTANCE; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUBERCULOSIS;

BLOTTING, NORTHERN; CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL9; HUMANS; INTERFERON-GAMMA; MYCOBACTERIUM TUBERCULOSIS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUBERCULOSIS; UP-REGULATION;

EID: 79551483205     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.11.005     Document Type: Article

References (77)

1. J.L. Flynn, and J. Chan Immunology of tuberculosis Annu Rev Immunol 19 2001 93 129
2. N.W. Schluger Recent advances in our understanding of human host responses to tuberculosis Respir Res 2 2001 157 163
3. R. van Crevel, T.H.M. Ottenhoff, and J.W.M. van der Meer Innate immunity to Mycobacterium tuberculosis Clin Microbiol Rev 15 2002 294 309
4. C.F. Nathan, H.W. Murray, M.E. Wiebe, and B.Y. Rubin Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity J Exp Med 158 1983 670 689
5. C.F. Nathan, T.J. Prendergast, M.E. Wiebe, E.R. Stanley, E. Platzer, and H.G. Remold Activation of human macrophages: comparison of other cytokines with interferon-gamma J Exp Med 160 1984 600 605
6. J.L. Flynn, J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection J Exp Med 178 1993 2249 2254
7. A.M. Cooper, D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme Disseminated tuberculosis in interferon gamma gene-disrupted mice J Exp Med 178 1993 2243 2247
8. M.J. Fenton, M.W. Vermeulen, S. Kim, M. Burdick, R.M. Strieter, and H. Kornfeld Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis Infect Immun 65 1997 5149 5156
9. A.M. Cooper, J.E. Pearl, J.V. Brooks, S. Ehlers, and I.M. Orme Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung Infect Immun 68 2000 6879 6882
10. D.M. Frucht, and S.M. Holland Defective monocyte costimulation for IFN-g production in familial disseminated Mycobacterium avium complex infection J Immunol 157 1996 411 416
11. C. Fieschi, S. Dupuis, C. Picard, and J.-L. Casanova Human interleukin-12-interferon-g axis in protective immunity to mycobacteria M. Kotb, T. Calandra, Cytokines and chemokines in infectious diseases handbook 2003 Humana Press Totowa, New Jersey 151 161
12. R. Bellamy Interferon-g and host susceptibility to tuberculosis Am J Respir Crit Care Med 167 2003 946 947
13. D. Lopez-Maderuelo, F. Arnalich, R. Serantes, A. Gonzalez, R. Codoceo, and R. Madero Interferon-g and interleukin-10 gene polymorphisms in pulmonary tuberculosis Am J Respir Crit Care Med 167 2003 970 975
14. R. Pine IRF and tuberculosis J Interferon Cytokine Res 22 2002 15 25
15. G. Chatte, G. OPanteix, M. Perrin-Fayolle, and Y. Pacheco Aerosolized interferon gamma for Mycobacterium avium-complex lung disease Am J Respir Crit Care Med 152 1995 1094 1096
16. J.I. Gallin, J.M. Farber, S.M. Holland, and T.B. Nutman Interferon-gamma in the management of infectious diseases Ann Intern Med 123 1995 216 224
17. C.F. Nathan, G. Kaplan, W.R. Levis, A. Nusrat, M.D. Witmer, and S.A. Sherwin Local and systemic effects of intradermal recombinant interferon-g in patients with lepromatous leprosy N Engl J Med 315 1986 6 15
18. S.M. Holland, E.M. Eisenstein, D.B. Kuhns, M.L. Turner, T.A. Fleisher, and W. Strober Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma N Engl J Med 330 1994 1348 1355
19. R.M. Rose, J.M. Fuglestad, and L. Remington Growth inhibition of Mycobacterium avium complex in human alveolar macrophages by the combination of recombinant macrophage colony-stimulating factor and interferon-gamma Am J Respir Cell Mol Biol 4 1991 248 254
20. K.E. Squires, S.T. Brown, D. Armstrong, W.F. Murphy, and H.W. Murray Interferon-g treatment for Mycobacterium avium-intracellulare complex bacillemia in patients with AIDS J Infect Dis 166 1992 686 687
21. R. Condos, W.N. Rom, and N.W. Schluger Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol Lancet 349 1997 1513 1515
22. C.G. Feng, C.M. Collazo-Custodio, M. Eckhaus, S. Hieny, Y. Belkaid, and K. Elkins Mice deficient in LRG-47 display increased susceptibility to mycobacterial infection associated with the induction of lymphopenia J Immunol 15 2004 1163 1168
23. J.D. MacMicking, G.A. Taylor, and J.D. McKinney Immune control of tuberculosis by IFN-g-inducible LRG-47 Science 302 2003 654 659
24. M.G. Gutierrez, S.S. Master, S.B. Singh, G.A. Taylor, M.I. Colombo, and V. Deretic Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages Cell 119 2004 753 766
25. G. Fenhalls, L. Stevens, J. Bezuidenhout, G.E. Amphlett, K. Duncan, and P. Bardin Distribution of IFN-g, IL-4 and TNF-a protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas Immunology 105 2002 325 335
26. A. Bergeron, M. Bonay, M. Kambouchner, D. Lecossier, M. Riquet, and P. Soler Cytokine patterns in tuberculous and sarcoid granulomas: Correlation with histopathologic features of the granulomatous response J Immunol 159 1997 3034 3043
27. G.A. Taylor, C.G. Feng, and A. Sher Control of IFN-g-mediated host resistance to intracellular pathogens by immunity-related GTPases (p47 GTPases) Microbes Infect 9 2007 1644 1651
28. G.S. Douvas, D.L. Looker, A.E. Vatter, and A.J. Crowle Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria Infect Immun 50 1985 1 8
29. G.A.W. Rook, J. Steele, M. Ainsworth, and B.R. Champion Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages Immunology 59 1986 333 338
30. S.M. Fortune, A. Solache, A. Jaeger, P.J. Hill, J.T. Belisle, and B.R. Bloom Mycobacterium tuberculosis inhibits macrophage responses to IFN-g through myeloid differentiation factor 88-dependent and -independent mechanisms J Immunol 172 2004 6272 6280
31. A.J. Gehring, M.E. Rojas, D.H. Canaday, D.L. Lakey, C.V. Harding, and W.H. Boom The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2 Infect Immun 71 2003 4487 4497
32. E.Z. Kincaid, and J.D. Ernst Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-g without inhibiting STAT1 function J Immunol 171 2003 2042 2049
33. V. Nagabhushanam, A. Solache, L.-M. Ting, C.J. Escaron, J.Y. Zhang, and J.D. Ernst Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma J Immunol 17 2003 4750 4757
34. E.H. Noss, R.K. Pai, T.J. Sellati, J.D. Radolf, J. Belisle, and D.T. Golenbock Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis J Immunol 167 2001 910 918
35. R.K. Pai, M. Convery, T.A. Hamilton, W.H. Boom, and C.V. Harding Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion J Immunol 171 2003 175 184
36. R.K. Pai, M.E. Pennini, A.A.R. Tobian, D.H. Canaday, W.H. Boom, and C.V. Harding Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma-interferon-induced regulation of selected genes in macrophages Infect Immun 72 2004 6603 6614
37. L.-M. Ting, A.C. Kim, A. Cattamanchi, and J.D. Ernst Mycobacterium tuberculosis inhibits IFN-g transcriptional responses without inhibiting activation of STAT1 J Immunol 163 1999 3898 3906
38. K. Imai, T. Kurita-Ochiai, and K. Ochiai Mycobacterium bovis bacillus Calmette-Guerin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages FEMS Immunol Med Microbiol 39 2003 173 180
39. G.R. Alvarez, B.S. Zwilling, and W.P. Lafuse Mycobacterium avium inhibition of IFN-g signaling in mouse macrophages: toll-like receptor 2 stimulation increases expression of dominant-negative STAT1b by mRNA stabilization J Immunol 171 2003 6766 6773
40. C. Abramo, K.E. Meijgaarden, D. Garcia, K.L.M.C. Franken, M.R. Klein, and A.J. Kolk Monokine induced by interferon gamma and IFN-g response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients Microbes Infect 8 2006 45 51
41. B. Raju, Y. Hoshino, K. Kuwabara, I. Belitskaya, S. Prabhakar, and A. Canova Aerosolized gamma interferon (IFN-g) induces expression of the genes encoding the IFN-g-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis Infect Immun 72 2004 1275 1283
42. S.A. Theus, M.D. Cave, and K.D. Eisenach Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates Infect Immun 72 2004 1169 1173
43. R.W. Stockes, and D. Doxsee The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages Cell Immunol 197 1999 1 9
44. C.J. Riendeau, and H. Kornfeld THP-1 cell apoptosis in response to Mycobacterial infection Infect Immun 71 2003 254 259
45. X. Bai, E.D. Chan, and X. Xu The protein of a new gene Tctex4 interacts with protein kinase CK2 [beta] subunit and is highly expressed in mouse testis Biochem Biophys Res Comm 307 2003 86 91
46. X. Bai, S.-H. Kim, T. Azam, M.T. McGibney, H. Huang, and C.A. Dinarello Interleukin-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages J Immunol 184 2010 3830 3840
47. L. Larsen, and C. Ropke Suppressors of cytokine signaling: SOCS APMIS 110 2002 833 844
48. J.J. O'Shea, M. Gadina, and R.D. Schreiber Cytokine signaling in 2002: new surprises in the Jak/Stat pathway Cell 109 2002 S121 S131
49. E.D. Chan, K.R. Morris, J.T. Belisle, P. Hill, L.K. Remigio, and P.J. Brennan Induction of inducible nitric oxide synthase-NO by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kB signaling pathways Infect Immun 69 4 2001 2001 2010
50. K.R. Morris, R.D. Lutz, H.-S. Choi, T. Kamitani, K. Chmura, and E.D. Chan Role of the NF-kB signaling pathway and kB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide Infect Immun 71 2003 1442 1452
51. A.D. Luster IP-10 J.J. Oppenheim, M. Feldmann, S.K. Durum, T. Hirano, J. Vilcek, N.A. Nicola, Cytokine reference 2001 Academic Press San Diego 1103 1109
52. J.M. Farber MIG J.J. Oppenheim, M. Feldmann, S.K. Durum, T. Hirano, J. Vilcek, N.A. Nicola, Cytokine reference 2001 Academic Press San Diego 1111 1117
53. H.M. Algood, P.L. Lin, D. Yankura, A. Jones, J. Chan, and J.L. Flynn TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection J Immunol 172 2004 6846 6857
54. C.S. Almeida, C. Abramo, C.C. Alves, L. Mazzoccoli, A.P. Ferreira, and H.C. Teixeira Anti-mycobacterial treatment reduces high plasma levels of CXC-chemokines detected in active tuberculosis by cytometric bead array Mem Inst Oswaldo Cruz 104 2009 1039 1041
55. Z. Hasan, B. Jamil, M. Ashraf, M. Islam, M.S. Yusuf, and J.A. Khan ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis PLoS One 4 2009 e5158
56. J. Lighter, M. Rigaud, M. Huie, C.H. Peng, and H. Pollack Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children Int J Tuberc Lung Dis 13 2009 731 736
57. S. Pokkali, and S.D. Das Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis Hum Immunol 70 2009 110 115
58. X. Bai, S.E. Wilson, K. Chmura, N.E. Feldman, and E.D. Chan Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis Tuberculosis (Edinb) 84 2004 375 385
59. C.L. Fuller, J.L. Flynn, and T.A. Reinhart In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis Infect Immun 71 2003 7023 7034
60. mapk in a mouse macrophage cell line Am J Physiol Cell Physiol 280 2001 C441 C450
61. E.D. Chan, B.W. Winston, S.-T. Uh, M.W. Wynes, D.M. Rose, and D.W.H. Riches Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFNg and TNFa in mouse macrophages J Immunol 162 1999 415 422
62. S. Radtke, S. Wüller, X.P. Yang, B.E. Lippok, B. Mütze, and C. Mais Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation J Cell Sci 123 2010 947 959
63. Y. Yao, Q. Xu, M.J. Kwon, R. Matta, Y. Liu, and S.C. Hong ERK and p38 MAPK signaling pathways negatively regulate CIITA gene expression in dendritic cells and macrophages J Immunol 177 2006 70 76
64. S. Joshi, S. Kaur, B. Kroczynska, and L.C. Platanias Mechanisms of mRNA translation of interferon stimulated genes Cytokine 52 2010 123 127
65. M. Brook, G. Sully, A.R. Clark, and J. Saklatvala Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade FEBS Lett 483 2000 57 61
66. H.B. Jijon, W.J. Panenka, K.L. Madsen, and H.G. Parsons MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism Am J Physiol Cell Physiol 283 2002 C31 C41
67. P. Ma, X. Cui, S. Wang, J. Zhang, E.V. Nishanian, and W. Wang Nitric oxide post-transcriptionally up-regulates LPS-induced IL-8 expression through p38 MAPK activation J Leukoc Biol 76 2004 278 287
68. K.R. Mahtani, M. Brook, J.L. Dean, G. Sully, J. Saklatvala, and A.R. Clark Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability Mol Cell Biol 21 2001 6461 6469
69. R.P. Cherla, S.Y. Lee, P.L. Mees, and V.L. Tesh Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line J Leukoc Biol 79 2006 397 407
70. Y. Yamagiwa, C. Marienfeld, L. Tadlock, and T. Patel Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth Hepatology 38 2003 158 166
71. Y. Yu, H. Zeng, S. Lyons, A. Carlson, D. Merlin, and A.S. Neish TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism Am J Physiol Gastrointest Liver Physiol 285 2003 G282 G290
72. K. Pazdrak, B. Olszewska-Pazdrak, T. Liu, R. Takizawa, A.R. Brasier, and R.P. Garofalo MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression Am J Physiol Lung Cell Mol Physiol 283 2002 L364 L372
73. K.R. Morris, R.D. Lutz, X. Bai, M.T. McGibney, D. Cook, and D. Ordway Suppression of IFNgamma+mycobacterial lipoarabinomannan-induced NO by IL-4 is due to decreased IRF-1 expression Tuberculosis (Edinb) 89 2009 294 303
74. J.B. Weinberg, M.A. Misukonis, P.J. Shami, S.N. Mason, D.L. Sauls, and W.A. Dittman Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages Blood 86 1995 1184 1195
75. E.A. Rich, M. Torres, E. Sada, C.K. Finegan, B.D. Hamilton, and Z. Toossi Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB Tuber Lung Dis 78 1997 247 255
76. J.S. Lee, C.S. Yang, D.M. Shin, J.M. Yuk, J.W. Son, and E.K. Jo Nitric oxide synthesis is modulated by 1,25-dihydroxyvitamin D3 and interferon-gamma in human macrophages after mycobacterial infection Immune Netw 9 2009 192 202
77. E.D. Chan, J. Chan, and N.W. Schluger What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge Am J Respir Cell Mol Biol 25 2001 606 612